CS logo
small CS logo
Kyoto University Hospital

Kyoto, Japan
University hospital in Kyoto
〒606-8507 Kyoto, Sakyo Ward, Shogoin Kawaracho, 54

About Kyoto University Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
16
Kyoto University
9
Pfizer
9
Takeda
8
Boehringer Ingelheim
4
Daiichi Sankyo, Inc.
4
Abbott Medical Devices
3
Actelion
3
Bristol-Myers Squibb
3
Eli Lilly and Company
3
Janssen Research & Development, LLC
3
Total Rows: 65

Clinical Trials at Kyoto University Hospital


During the past decade, Kyoto University Hospital conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 33 clinical trials were completed, i.e. on average, 37.9% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 16 clinical trials were completed. i.e. 47.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years8877111114141313141412126622113355117766444422Started TrialsCompleted Trails201520162017201820192020202120222023051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
2001-07-01
2010-09-01
Completed
1,030
S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
2003-04-01
Unknown status
50
Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
2005-03-01
2014-02-01
Completed
474
Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer
2004-05-01
2008-11-01
Completed
30
Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy
2004-05-01
2016-05-01
Completed
200
A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
2000-11-01
2007-01-01
Completed
690
S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer
2004-04-01
2008-11-01
Completed
100
A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma
2000-05-01
2009-05-01
Terminated
330

Rows per page:

1–100 of 143

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kyoto University Hospital" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "Kyoto University" with 9 trials sponsored, "Pfizer" with 9 trials sponsored, "Takeda" with 8 trials sponsored and "Boehringer Ingelheim" with 8 trials sponsored. Other sponsors include 92 different institutions and companies that sponsored additional 65 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kyoto University Hospital" #1 collaborator was "Kyoto University" with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 4 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator and "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 71 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 16Hoffmann-La Roche: 16Kyoto University: 9Kyoto University: 9Pfizer: 9Pfizer: 9Takeda: 8Takeda: 8Boehringer Ingelheim: 4Boehringer Ingelheim: 4Daiichi Sankyo, Inc.: 4Daiichi Sankyo, Inc.: 4Abbott Medical Devices: 3Abbott Medical Devices: 3Actelion: 3Actelion: 3Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3Eli Lilly and Company: 3Eli Lilly and Company: 3

Created with Highcharts 11.1.0Top CollaboratorsKyoto University: 5Kyoto University: 5AstraZeneca: 4AstraZeneca: 4Ministry of Health,Labour and Welfare,Japan: 4Ministry of Health,Labour and Welfare,Japan: 4Breast International Group: 3Breast International Group: 3Eli Lilly and Company: 3Eli Lilly and Company: 3Japan Lung Cancer Society: 2Japan Lung Cancer Society: 2NSABP Foundation Inc: 2NSABP Foundation Inc: 2Philips Respironics: 2Philips Respironics: 2ADIR, a Servier Groupcompany: 1ADIR, a Servier Groupcompany: 1Alliance FoundationTrials (AFT): 1Alliance FoundationTrials (AFT): 1

Clinical Trials Conditions at Kyoto University Hospital


According to Clinical.Site data, the most researched conditions in "Kyoto University Hospital" are "Breast Cancer" (10 trials), "Coronary Artery Disease" (7 trials), "Gastric Cancer" (4 trials), "Ovarian Cancer" (4 trials) and "Biliary Tract Cancer" (3 trials). Many other conditions were trialed in "Kyoto University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Kyoto University Hospital


Most popular intervention types in "Kyoto University Hospital" are "Drug" (116 trials), "Device" (16 trials), "Other" (13 trials), "Procedure" (13 trials) and "Biological" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (22 trials), "Atezolizumab" (7 trials), "Cisplatin" (6 trials), "Gemcitabine" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

Clinical Trials Genders at Kyoto University Hospital


The vast majority of trials in "Kyoto University Hospital" are 122 trials for "All" genders, 15 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at Kyoto University Hospital


Currently, there are NaN active trials in "Kyoto University Hospital". undefined are not yet recruiting, 26 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Kyoto University Hospital, undefined suspended trials, and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Kyoto University Hospital, 12 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 77Phase 3: 77Phase 2: 36Phase 2: 36Not Applicable: 13Not Applicable: 13Phase 1: 12Phase 1: 12Phase 4: 4Phase 4: 4

Created with Highcharts 11.1.0Trials StatusCompleted: 67Completed: 67Active, not recruiting: 30Active, not recruiting: 30Recruiting: 26Recruiting: 26Unknown status: 11Unknown status: 11Terminated: 8Terminated: 8Withdrawn: 1Withdrawn: 1